All Articles

CurifyLabs just raised $14M to put 3D printers in pharmacies. It’s more than a tech play; it’s a calculated bet on a new era of personalized medicine.

As content demands soar, new AI tools from Krikey AI promise studio-level animation in minutes, solving the creator crunch but raising new questions.

AXA XL's appointment of Matt Rodliff as Americas Claims Chief is more than a new hire; it's a strategic pivot towards a future where data and technology redefine risk.

The arrival of Dr. Jamie Stanhiser at RMA San Diego is more than a new hire; it’s a calculated move by a global giant to deepen its US market penetration.

The era of Global Capability Centers being exclusive to giant multinationals is over. A new report reveals a surge of smaller, private, and AI-native firms.

By tapping David Schmidt, a leader known for high-growth turnarounds, Electro Switch is betting big on its aerospace and defense segment. What does this signal?

CohnReznick's acquisition of Houston's HL&B isn't just a deal; it's a strategic masterstroke fueled by private equity, reshaping the professional services landscape.

A look inside Eurokid's latest announcement reveals a larger strategy by educational giants to architect the future of learning from the ground up.

Trecora’s surcharge removal offers customer relief, but what does it signal for the volatile chemical industry? A deeper look at a strategic market play.

Partnership on AI has a new plan to verify ethical AI promises with data. But in a world of 'ethics washing,' can a voluntary system truly build trust?

As VOMO surpasses 400,000 users, it's clear the demand for AI meeting notes is exploding. But its true innovation lies in connecting conversations to the emerging agent economy.

As Envita Solutions marks a quarter-century, we examine how a niche player uses data and family backing to tackle the colossal challenge of industrial waste.

A new survey reveals most Americans don't know real ice cream from its imposters. We dissect the labels and expose the billion-dollar battle in the freezer aisle.

As Genomma Lab prepares its Q2 2026 earnings call, investors are watching if its famed operational network can navigate a weak Mexican market and margin pressures.

A Brazilian research group launches the world's first graduate program in Ufology, promising scientific rigor. But can it overcome its founder's controversial past?

A landmark summit unites Michael Jordan, DraftKings, and Sportradar. We dissect how these titans are building a new world where every fan is a player.

A nonprofit giveaway of baby supplies is more than a feel-good story; it's a data-backed strategy with a 4x return on investment for taxpayers.

As a uranium boom grips Saskatchewan, the Clearwater River Dene Nation is taking control with a monitoring checkpoint, a bold move setting a new precedent.

DexKo Global installs Eric McGinnis, a proven transformation leader, as its new CEO, signaling a shift from foundational stability to aggressive innovation.